Speculating in Takeover Targets Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Speculating in Takeover Targets

ULBI 6.950

-1.1%

9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: richardred who wrote (2429)	5/4/2012 10:51:10 PM
From: richardred	of 7239

KNSY- Never re-entered- Oh-Well That's the way the cookie crumbles. Move on, and find the next one. DSM to buy U.S. biomedical firm Kensey Nash (Reuters) - Dutch food and chemicals group DSM ( DSMN.AS) is buying U.S. medical device-maker Kensey Nash Corp ( KNSY.O) for $360 million to strengthen its biomedical business, leaving it with plenty of cash for more deals. in.reuters.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next